UW Health Pediatric Clinics
Madison, Wisconsin, 53717, United States
Location status: Recruiting
Location contact
Bridget Johnson, BAN,RN,CCRC
CONTACT
Ellen R Wald, MD
SUB_INVESTIGATOR
Gregory DeMuri, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT01558804
The purpose of the research is to help understand why some children become carriers of strep and whether children who are carriers need to be treated with antibiotics.
Interested in participating?
Request Info5 year–15 year
All sexes
Observational
Madison, Wisconsin, 53717, United States
Location status: Recruiting
Bridget Johnson, BAN,RN,CCRC
CONTACT
Ellen R Wald, MD
SUB_INVESTIGATOR
Gregory DeMuri, MD
PRINCIPAL_INVESTIGATOR
The overall objective of this investigation is to understand the differences in Group A streptococci in children who are acutely infected from those who are carriers. The hypothesis is that when in the carrier state, GAS exhibits unique transcriptional profiles that differ from those of the acute infection state. The investigators expect transcriptional profiles of GAS to provide important information regarding the changes the organism undergoes when transitioning between acute infection and carriage.
The specific aims of this study are:
To do this, the investigators will to identify 12 children with acute pharyngitis due to Group A streptococcus (GAS) who are pharyngeal carriers of GAS. Thirty percent of children 4 to 16 years of age with acute pharyngitis occurring between October and May will have a positive culture or rapid antigen detection test for GAS. Approximately 8-10% of these children with pharyngitis and a positive culture or rapid antigen detection test (RADT) for GAS will be carriers. Therefore,180 participants will need to be enrolled.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
At study entry, at 14 days, and if follow up is positive, again in 14-21 days: Standard culture for GAS and analysis of mRNA.
Time frame: 2 weeks
The specific aim of this study is to identify 30 children with acute pharyngitis due to Group A streptococcus (GAS) and 30 children who are pharyngeal carriers of GAS.
Thirty percent of children 4 to 16 years of age with acute pharyngitis occurring between October and May will have a positive culture or rapid antigen detection test for GAS. Approximately 10-15% of these children with pharyngitis and a positive culture or rapid antigen detection test (RADT) for GAS will be carriers
Contact information is provided by the study sponsor or research team.
University of Wisconsin, Madison
Other
Gene Expression in Isolates of Group A Streptococci Recovered From Patients Who Are Carriers
Acronym: GRASP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05521568
Hypersensitivity, Immune System Diseases
Saint-Maur-des-Fossés, France
View Trial DetailsNCT04247243
Streptococcal Pharyngitis
Hamilton, Ontario, Canada
View Trial DetailsNCT01806103
Acute Sinusitis, Infections
Philadelphia, Pennsylvania, United States
View Trial Details